The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a bivalent COVID booster vaccine, making it the first country in the world to do so.
Developed by Moderna, this vaccine has been approved for use in adults, and is set to form part of the upcoming autumn booster campaign in the UK.
But what actually is a bivalent vaccine, and what impact might this booster have on the trajectory of the pandemic? Let’s take a look.
